Establishment of novel embryonic stem (ES) cell lines from OG2/rtTA blastocysts

Journal of Genetics and Genomics

Volumn 38, Issue 7, 2011, Pages 289-295

  Yao, Hui ^a,b   Jiang, Yonghua ^b   Zhang, Yu ^b   Liu, Wenqiang ^b   Huang, Bo ^b   Wang, Xiaodong ^a,b   Gao, Shaorong ^b  

^a BEIJING NORMAL UNIVERSITY   (China)

^b NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES   (China)

Author keywords

Embryonic stem (ES) cells; Oct4; RtTA

Indexed keywords

DOXYCYCLINE; GREEN FLUORESCENT PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLASTOCYST; CELL LINE; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; FEMALE; FLUORESCENCE MICROSCOPY; GERM LINE; MALE; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; TRANSGENIC MOUSE;

ANIMALS; BLASTOCYST; CELL LINE; CROSSES, GENETIC; EMBRYONIC STEM CELLS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GREEN FLUORESCENT PROTEINS; MALE; MICE; MICE, TRANSGENIC; NUCLEAR REPROGRAMMING; OCTAMER TRANSCRIPTION FACTOR-3; PLURIPOTENT STEM CELLS; TERATOMA;

MUS; MUS MUSCULUS;

EID: 79960460802     PISSN: 16738527     EISSN: 18735533     Source Type: Journal    
DOI: 10.1016/j.jgg.2011.05.007     Document Type: Article

References (27)

1. Brambrink T., Foreman R., Welstead G.G., Lengner C.J., Wernig M., Suh H., Jaenisch R. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2008, 2:151-159.
2. Evans M.J., Kaufman M.H. Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292:154-156.
3. Gimenez E., Lavado A., Giraldo P., Cozar P., Jeffery G., Montoliu L. A transgenic mouse model with inducible Tyrosinase gene expression using the tetracycline (Tet-on) system allows regulated rescue of abnormal chiasmatic projections found in albinism. Pigment Cell Res. 2004, 17:363-370.
4. Guo Z.M., Xu K., Yue Y., Huang B., Deng X.Y., Zhong N.Q., Hong X., Chen X.G., Xiao D. Temporal control of Cre recombinase-mediated in vitro DNA recombination by Tet-on gene expression system. Acta Biochim. Biophys. Sin. 2005, 37:133-138.
5. Hall J., Guo G., Wray J., Eyres I., Nichols J., Grotewold L., Morfopoulou S., Humphreys P., Mansfield W., Walker R., Tomlinson S., Smith A. Oct4 and LIF/Stat3 additively induce Kruppel factors to sustain embryonic stem cell self-renewal. Cell Stem Cell 2009, 5:597-609.
6. Hiroyama T., Miharada K., Sudo K., Danjo I., Aoki N., Nakamura Y. Establishment of mouse embryonic stem cell-derived erythroid progenitor cell lines able to produce functional red blood cells. PLoS ONE 2008, 3:e1544.
7. Jaenisch R., Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 2008, 132:567-582.
8. Kang L., Wang J., Zhang Y., Kou Z., Gao S. iPS cells can support full-term development of tetraploid blastocyst-complemented embryos. Cell Stem Cell 2009, 5:135-138.
9. Kawamura T., Suzuki J., Wang Y.V., Menendez S., Morera L.B., Raya A., Wahl G.M., Belmonte J.C. Linking the p53 tumour suppressor pathway to somatic cell reprogramming. Nature 2009, 460:1140-1144.
10. Lottmann H., Vanselow J., Hessabi B., Walther R. The Tet-on system in transgenic mice: inhibition of the mouse pdx-1 gene activity by antisense RNA expression in pancreatic beta-cells. J. Mol. Med. 2001, 79:321-328.
11. Martin G.R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 1981, 78:7634-7638.
12. Masui S., Nakatake Y., Toyooka Y., Shimosato D., Yagi R., Takahashi K., Okochi H., Okuda A., Matoba R., Sharov A.A., Ko M.S., Niwa H. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat. Cell Biol. 2007, 9:625-635.
13. Mitsui K., Tokuzawa Y., Itoh H., Segawa K., Murakami M., Takahashi K., Maruyama M., Maeda M., Yamanaka S. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 2003, 113:631-642.
14. Nagy Z.P. Micromanipulation of the human oocyte. Reprod. Biomed. Online 2003, 7:634-640.
15. Niwa H., Miyazaki J., Smith A.G. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 2000, 24:372-376.
16. Pan G., Li J., Zhou Y., Zheng H., Pei D. A negative feedback loop of transcription factors that controls stem cell pluripotency and self-renewal. FASEB J. 2006, 20:1730-1732.
17. Reboredo M., Kramer M.G., Smerdou C., Prieto J., De Las Rivas J. Transcriptomic effects of Tet-on and mifepristone-inducible systems in mouse liver. Hum. Gene Ther. 2008, 19:1233-1247.
18. Song X., Guo Y., Duo S., Che J., Wu C., Ochiya T., Ding M., Deng H. A mouse model of inducible liver injury caused by tet-on regulated urokinase for studies of hepatocyte transplantation. Am. J. Pathol. 2009, 175:1975-1983.
19. Stadtfeld M., Maherali N., Breault D.T., Hochedlinger K. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2008, 2:230-240.
20. Strubing C., Ahnert-Hilger G., Shan J., Wiedenmann B., Hescheler J., Wobus A.M. Differentiation of pluripotent embryonic stem cells into the neuronal lineage in vitro gives rise to mature inhibitory and excitatory neurons. Mech. Dev. 1995, 53:275-287.
21. Sun Y., Chen X., Xiao D. Tetracycline-inducible expression systems: new strategies and practices in the transgenic mouse modeling. Acta Biochim. Biophys. Sin. 2007, 39:235-246.
22. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
23. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
24. Takiguchi M., James C., Josefsson E.C., Carmichael C.L., Premsrirut P.K., Lowe S.W., Hamilton J.R., Huang D.C., Kile B.T., Dickins R.A. Transgenic, inducible RNAi in megakaryocytes and platelets in mice. J. Thromb. Haemost. 2010, 8:2751-2756.
25. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science 1998, 282:1145-1147.
26. Vieyra D.S., Goodell M.A. Pluripotentiality and conditional transgene regulation in human embryonic stem cells expressing insulated tetracycline-ON transactivator. Stem Cells 2007, 25:2559-2566.
27. Wobus A.M., Boheler K.R. Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol. Rev. 2005, 85:635-678.